CIAMEDIUM SIGNALFINANCIAL10-K

CIA experienced meaningfully reduced operating cash flow alongside modest improvements in stockholder equity, indicating mixed operational and financial performance.

The substantial decline in operating cash flow from $31.9M to $18.0M suggests potential challenges in the company's core business operations or working capital management that warrant investor attention. However, the increase in stockholder equity to $235.0M demonstrates continued balance sheet strengthening, providing some financial stability despite operational headwinds.

Comparing 2026-03-12 vs 2025-03-13View on EDGAR →
FINANCIAL ANALYSIS

CIA's financial profile shows divergent trends with operating cash flow declining notably to $18.0M while stockholder equity grew modestly to $235.0M. Cash and equivalents decreased to $23.0M, though this remains at healthy levels, while capital expenditure was reduced to $447K. The overall picture suggests a company managing through operational challenges while maintaining solid balance sheet fundamentals.

FINANCIAL STATEMENT CHANGES
Operating Cash Flow
Cash Flow
-43.6%
$31.9M$18.0M

Operating cash flow fell 43.6% — earnings quality concerns; investigate working capital changes and non-cash items.

Capital Expenditure
Cash Flow
-32.6%
$663K$447K

Capex reduced 32.6% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-21.5%
$29.3M$23.0M

Cash decreased 21.5% — monitor burn rate and upcoming capital needs.

Stockholders Equity
Balance Sheet
+11.7%
$210.4M$235.0M

Equity base grew 11.7% — retained earnings accumulation or equity issuance strengthening the balance sheet.

LANGUAGE CHANGES
NEW — 2026-03-12
PRIOR — 2025-03-13
ADDED
As of March 6, 2026, the Registrant had 50,299,741 shares of Class A common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 24 Item 7A.
Forward-looking statements are typically identified by words such as anticipates, believes, estimates, expects, intends, "may," plans, predicts, "projects," "seeks," "should," will, and similar expressions, although not all forward looking statements contain these identifying words.
These statements include, among other things, statements regarding our future results of operations and financial position, business strategy, expectations regarding capital needs, and objectives for future operations.
Forward-looking statements are based on our current expectations, assumptions and projections about future events and trends that we believe may affect our business, financial condition, results of operations or prospects.
+7 more — sign up free →
REMOVED
As of March 10, 2025, the Registrant had 49,907,355 shares of Class A common stock outstanding.
Management's Discussion and Analysis of Financial Condition and Results of Operations 27 Item 7A.
All statements contained in this Form 10-K other than statements of historical fact, including statements regarding our future results of operations and financial position, our business strategy and plans, our expected capital needs, and our objectives for future operations, are forward-looking statements.
Forward-looking statements may be identified by words such as future, anticipates, believes, estimates, expects, intends, plans, predicts, will, would, could, can, may, and similar terms.
We have based these forward-looking statements largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
CRMHIGHSalesforce significantly increased debt by 71% to $14.4B while simultaneously ac...
2026-03-02
UNHHIGHUNH's operating income plummeted 41% despite 12% revenue growth, indicating seve...
2026-03-02
PFEHIGHPfizer achieved a dramatic 87.3% reduction in total debt from $31.4B to $4.0B, r...
2026-02-26
GILDHIGHGILD dramatically increased R&D spending by 81.5% to $9.1B while introducing new...
2026-02-24
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →